Andrew Parker on Muck Rack

Andrew Parker

Leesburg
As seen in: MIT Sloan Management Review, The Mercury (South Africa), Lexology, HORIZONT, TextilWirtschaft, Good Things Guy, Buxton Advertiser, Canadian Mining Journal, The Medicine Maker, RAPP Worldwide and
Musician, author, editor, cook, Virginia bred.
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Andrew

Contact Andrew, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

The right equipment investments can help mining operations lower maintenance costs

|
By Andrew Parker
| Canadian Mining Journal Verified
Constant dust, heat, toxic substances, and crowded spaces pose significant challenges for material handling equipment, and unplanned downtime is potentially catastrophic for an operation. Credit: CDM System Mining operations strive to be safe, efficient, and productive, but they often allocate up to 50% of their annual budget to equipment maintenance to keep things running. How can operations run smoothly to actualize lofty production goals if you are constantly throwing money at repairs?
Open in Who Shared Issue with article?

11.11.25 -- OpenFold3 Redefining The Limits Of Protein Prediction Models

|
By Ray Dogum, Andrew Parker, David Lyon Verified, Molly Adam
OpenFold3, a biomolecular structure prediction model based on AlphaFold3 was recently released by the OpenFold Consortium, a non-profit AI R&D organization. Expanding A Single Mechanism Through Genetic Logic And Clinical Observation With the right biology, a single mechanism can open multiple clinically meaningful avenues for oncology drug development. Step Pharma CEO discusses their clinical development programs for oncology.
Open in Who Shared Issue with article?

Expanding A Single Mechanism Through Genetic Logic And Clinical Observation

|
By Andrew Parker
By Andrew Parker, Ph.D., CEO, Step Pharma In oncology drug development, the assumption has often been that success comes from breadth: multiple assets, multiple targets. But our experience at Step Pharma suggests a different path is possible: with the right biology, a single mechanism can open multiple clinically meaningful avenues.
Open in Who Shared Issue with article?
See all 23 licensed articles (28 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified